Stolk RP - Search Results

1

Cardiovascular drug use and hospitalizations attributable to type 2 diabetes.

Erkens JA, Klungel OH, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG. Erkens JA, et al. Among authors: stolk rp. Diabetes Care. 2001 Aug;24(8):1428-32. doi: 10.2337/diacare.24.8.1428. Diabetes Care. 2001. PMID: 11473081

2

Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients.

Erkens JA, Klungel OH, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG. Erkens JA, et al. Among authors: stolk rp. Eur Heart J. 2002 Oct;23(20):1575-9. doi: 10.1053/euhj.2002.3173. Eur Heart J. 2002. PMID: 12323156

3

Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice.

Spoelstra JA, Stolk RP, Klungel OH, Erkens JA, Rutten GE, Leufkens HG, Grobbee DE. Spoelstra JA, et al. Among authors: stolk rp. Diabet Med. 2004 Aug;21(8):896-900. doi: 10.1111/j.1464-5491.2004.01273.x. Diabet Med. 2004. PMID: 15270794

4

Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients.

Erkens JA, Klungel OH, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG. Erkens JA, et al. Among authors: stolk rp. Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):139-46. doi: 10.1002/pds.932. Pharmacoepidemiol Drug Saf. 2004. PMID: 15072112

5

Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus.

Spoelstra JA, Stolk RP, Cohen D, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE. Spoelstra JA, et al. Among authors: stolk rp. J Clin Psychiatry. 2004 May;65(5):674-8. doi: 10.4088/jcp.v65n0512. J Clin Psychiatry. 2004. PMID: 15163254

6

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

Cohen D, Stolk RP, Grobbee DE, Gispen-de Wied CC. Cohen D, et al. Among authors: stolk rp. Diabetes Care. 2006 Apr;29(4):786-91. doi: 10.2337/diacare.29.04.06.dc05-1261. Diabetes Care. 2006. PMID: 16567816 Free article.

7

Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus.

Erkens JA, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG. Erkens JA, et al. Among authors: stolk rp. J Clin Epidemiol. 2002 Apr;55(4):345-9. doi: 10.1016/s0895-4356(01)00482-6. J Clin Epidemiol. 2002. PMID: 11927201

8

Why use the oral glucose tolerance test?

Stolk RP, Orchard TJ, Grobbee DE. Stolk RP, et al. Diabetes Care. 1995 Jul;18(7):1045-9. doi: 10.2337/diacare.18.7.1045. Diabetes Care. 1995. PMID: 7555541 Review. No abstract available.

9

Plasma fibrinogen in NIDDM: the Rotterdam study.

Missov RM, Stolk RP, van der Bom JG, Hofman A, Bots ML, Pols HA, Grobbee DE. Missov RM, et al. Among authors: stolk rp. Diabetes Care. 1996 Feb;19(2):157-9. doi: 10.2337/diacare.19.2.157. Diabetes Care. 1996. PMID: 8718437

10

Insulin and cognitive function in an elderly population. The Rotterdam Study.

Stolk RP, Breteler MM, Ott A, Pols HA, Lamberts SW, Grobbee DE, Hofman A. Stolk RP, et al. Diabetes Care. 1997 May;20(5):792-5. doi: 10.2337/diacare.20.5.792. Diabetes Care. 1997. PMID: 9135944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page